PrintMAGAZINE
The Journal of Life Sciences
Fall 2009: The Personalized Medicine Issue[Please login to post comments]
- A Healthcare Carol
Getting the dickens scared out of you by reform efforts. Read More - No Deal
Facet rejects Biogen’s $493 million offer, looks for new buyer Read More - Making Sense of a Tumultuous Year
Podcast: December 18, 2009 Read More - A Vote of Confidence
Seattle Genetics nails $365 million cancer drug deal with Takeda Read More - Curbing the Appetite
Controlling a key enzyme in the brain may lay the groundwork for treating obesity. Read More - Beta Islet Cell Phones
Mobile phones could help parents monitor blood sugar of their diabetic children. Read More - After failure, Gilead Likely to Discontinue Development of Hypertension Drug
The weekly round-up of failed trials, missed targets and other business mishaps. Read More - A Victory for Big Pharma
U.S. Senate rejects amendment that would have permitted drug reimportation. Read More - Astellas' Ambit Gambit
Japanese Pharma enters into a $390 million oncology deal with San Diego biotech. Read More - Imitating Life
Synthetic red blood cells carry drugs, diagnostic agents. Read More
.jpg)
.gif)
.gif)
.gif)
- Senate on track to pass healthcare bill
Reuters - Deep in Health Bill, Very Specific Beneficiaries
The New York Times - Former CDC head lands vaccine job at Merck
Reuters - Senate Debate on Health Care Exacerbates Partisanship
The New York Times - The Virtual Visit May Expand Access to Doctors
The New York Times - Health Bill Passes Key Test in the Senate With 60 Votes
The New York Times - Obama faces healthcare insurrection from left flank
Reuters - Democrat rejects health bill compromise
Reuters - In Senate Health Showdown, Round Goes to G.O.P.
The New York Times - Heart disease to cost U.S $503 billion in 2010: group
Reuters